<DOC>
	<DOCNO>NCT03083197</DOCNO>
	<brief_summary>Study type : Randomized Control Treatment Trial Study population : Male female patient ≥15 year age acute scrub typhus Duration : 2 year Study Design : Prospective , open-label , randomized-controlled treatment trial patient ≥15 year old admit hospital acute scrub typhus . Randomization 3 oral treatment arm ( n=59 patient , total n=177 ) : ) 7 day doxycycline , ii ) 3 day doxycycline , iii ) 3 day azithromycin Primary Objective : To evaluate clinical microbiological response scrub typhus patient three oral treatment regimen : 7 day doxycycline , 3 day doxycycline , 3 day azithromycin Secondary Objectives : 1 . To perform pharmacokinetic/pharmacodynamics ( PK/PD ) characterization therapeutic response doxycycline azithromycin , incl . serial bacterial load measurement . 2 . To define clinical , bacterial , pathophysiological pharmacological factor associate disease severity , fever-clearance time ( FCT ) , treatment failure relapse/re-infection . 3 . To determine minimum inhibitory concentration ( MIC ) clinical Orientia tsutsugamushi isolate doxycycline , azithromycin chloramphenicol , use vitro growth-inhibition assay 4 . To genotype clinical isolates use whole genome sequence comparative genomics . 5 . To dissect natural immune response scrub typhus , use antigen-specific cellular immune antibody study , cytokine profiling</brief_summary>
	<brief_title>Scrub Typhus Antibiotic Resistance Trial</brief_title>
	<detailed_description />
	<mesh_term>Typhus , Epidemic Louse-Borne</mesh_term>
	<mesh_term>Scrub Typhus</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Doxycycline</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>Age ≥ 15 year old Hospitalization acute undifferentiated fever ( temperature &gt; 37.5°C , tympanic ) ≤14 day patient admitted hospital history fever ≤ 14 day subsequently develop fever within 24 hour admission Clinically suspect scrub typhus : define acute undifferentiated fever clear focus infection negative malaria blood smear and/or negative malaria RDT . Patients may one , none , combination clinical finding eschar , rash , lymphadenopathy , headache , myalgia , cough , nausea abdominal discomfort . A positive scrub typhus RDT ( Scrub Typhus IgM RDT , InBios International , Seattle , WA , USA ) and/or positive PCRbased detection O. tsutsugamushi DNA admission blood sample Written inform consent and/or , write informed assent require Able take oral medication Known hypersensitivity tetracycline , doxycycline azithromycin Administration doxycycline , azithromycin , chloramphenicol , rifampicin , tetracycline precede 7 day Pregnancy breastfeed Patients myasthenia gravis systemic lupus erythematosus Patients establish infection ( diagnostic test require ) e.g . acute malaria , dengue , leptospirosis , typhoid , Japanese encephalitis etc . Current TB TB treatment ≤ 6 month ( contain active antibiotic Orientia spp . ) Current HAART use HIV , long term use immunosuppressant ( e.g . steroid , chemotherapy , TNFinhibitors relate agent ) Patients severe disease clinical team feel condition necessitates need additional scrub typhus treatment beyond allocate antibiotic treatment assign randomization ( e.g . IV chloramphenicol and/or PO/NG rifampicin )</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Scrub Typhus</keyword>
	<keyword>Antibiotic Resistance</keyword>
</DOC>